ABERCROMBIE & FITCH CO /DE/ Quarterly Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents in USD from Q4 2015 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.
Summary
Abercrombie & Fitch Co /De/ quarterly Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents history and growth rate from Q4 2015 to Q3 2024.
  • Abercrombie & Fitch Co /De/ Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents for the quarter ending November 2, 2024 was $691M, a 4.99% increase year-over-year.
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Quarterly (USD)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $691M +$32.9M +4.99% Nov 2, 2024 10-Q 2024-12-06
Q2 2024 $746M +$119M +19% Aug 3, 2024 10-Q 2024-09-06
Q1 2024 $872M +$415M +91% May 4, 2024 10-Q 2024-06-07
Q4 2023 $910M +$382M +72.4% Feb 3, 2024 10-Q 2024-12-06
Q3 2023 $658M +$391M +146% Oct 28, 2023 10-Q 2024-12-06
Q2 2023 $627M +$247M +65% Jul 29, 2023 10-Q 2024-09-06
Q1 2023 $457M -$21.8M -4.56% Apr 29, 2023 10-Q 2024-06-07
Q4 2022 $528M -$307M -36.8% Jan 28, 2023 10-Q 2024-12-06
Q3 2022 $267M -$613M -69.7% Oct 29, 2022 10-Q 2023-12-04
Q2 2022 $380M -$556M -59.4% Jul 30, 2022 10-Q 2023-09-01
Q1 2022 $478M -$446M -48.2% Apr 30, 2022 10-Q 2023-06-06
Q4 2021 $834M -$290M -25.8% Jan 29, 2022 10-K 2024-04-01
Q3 2021 $880M +$48.5M +5.83% Oct 30, 2021 10-Q 2022-12-06
Q2 2021 $936M +$150M +19.1% Jul 31, 2021 10-Q 2022-09-07
Q1 2021 $924M +$202M +28% May 1, 2021 10-Q 2022-06-08
Q4 2020 $1.12B +$432M +62.4% Jan 30, 2021 10-K 2024-04-01
Q3 2020 $832M +$400M +92.5% Oct 31, 2020 10-Q 2021-12-06
Q2 2020 $786M +$265M +50.8% Aug 1, 2020 10-Q 2021-09-08
Q1 2020 $722M +$115M +18.9% May 2, 2020 10-Q 2021-06-09
Q4 2019 $692M -$53.6M -7.18% Feb 1, 2020 10-K 2023-03-27
Q3 2019 $432M -$110M -20.3% Nov 2, 2019 10-Q 2020-12-07
Q2 2019 $521M -$82M -13.6% Aug 3, 2019 10-Q 2020-09-08
Q1 2019 $608M -$7M -1.14% May 4, 2019 10-Q 2020-06-10
Q4 2018 $746M +$47.9M +6.86% Feb 2, 2019 10-K 2022-03-28
Q3 2018 $542M +$61M +12.7% Nov 3, 2018 10-Q 2019-12-11
Q2 2018 $603M +$160M +36.1% Aug 4, 2018 10-Q 2019-09-11
Q1 2018 $615M +$173M +39.1% May 5, 2018 10-Q 2019-06-12
Q4 2017 $698M +$130M +23% Feb 3, 2018 10-K 2021-03-29
Q3 2017 $481M Oct 28, 2017 10-Q 2018-12-12
Q2 2017 $443M Jul 29, 2017 10-Q 2018-09-10
Q1 2017 $442M Apr 29, 2017 10-Q 2018-06-08
Q4 2016 $568M -$41.5M -6.82% Jan 28, 2017 10-K 2020-03-31
Q4 2015 $609M Jan 30, 2016 10-K 2019-04-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.